Roche turns to Dualitas to find new bispecific approaches for immunology
Roche is turning up the heat on its hunt for next-generation bispecific antibodies in a deal that will involve screening 300,000 new combinations for inflammatory and immunology conditions. The Swiss pharma is delivering $36.5 million ...
We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.
Also reported by 1 other outlet
- Roche, Dualitas team up to find bispecific drugs for immune diseases biopharmadive.com
